These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. Eagan TM; Hardie JA; Jul-Larsen Å; Grydeland TB; Bakke PS; Cox RJ Respir Med; 2016 Jun; 115():53-9. PubMed ID: 27215504 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease. Li Y; Ma Y; An Z; Yue C; Wang Y; Liu Y; Yuan X; Zhang S; Shao M; Li C; Li K; Yin Z; Wang L; Wang H Hum Vaccin Immunother; 2021 Sep; 17(9):3131-3136. PubMed ID: 33984257 [No Abstract] [Full Text] [Related]
5. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients. Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296 [TBL] [Abstract][Full Text] [Related]
6. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure. Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A Front Immunol; 2018; 9():2465. PubMed ID: 30405641 [No Abstract] [Full Text] [Related]
7. Factors associated with humoral immune response in older adults who received egg-free influenza vaccine. Williams KV; Moehling Geffel K; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Susick M; Zimmerman RK Vaccine; 2023 Jan; 41(3):862-869. PubMed ID: 36543682 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C. Ohfuji S; Fukushima W; Tamori A; Maeda K; Maeda A; Hirota Y Influenza Other Respir Viruses; 2013 May; 7(3):456-65. PubMed ID: 22897938 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. Huijskens E; Rossen J; Mulder P; van Beek R; van Vugt H; Verbakel J; Rimmelzwaan G; Koopmans M; Peeters M Clin Vaccine Immunol; 2011 Sep; 18(9):1401-5. PubMed ID: 21795459 [TBL] [Abstract][Full Text] [Related]
10. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers. Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721 [TBL] [Abstract][Full Text] [Related]
11. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864 [TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects. Agrati C; Castilletti C; Cimini E; Lapa D; Quartu S; Caglioti C; Lanini S; Cattoli G; Martini F; Ippolito G; Capobianchi MR PLoS One; 2014; 9(8):e105651. PubMed ID: 25162670 [TBL] [Abstract][Full Text] [Related]
13. The immunogenicity of the intradermal injection of seasonal trivalent influenza vaccine containing influenza A(H1N1)pdm09 in COPD patients soon after a pandemic. Chuaychoo B; Kositanont U; Rittayamai N; Niyomthong P; Songserm T; Maranetra KN; Rattanasaengloet K; Nana A Hum Vaccin Immunother; 2016 Jul; 12(7):1728-37. PubMed ID: 27153158 [TBL] [Abstract][Full Text] [Related]
15. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects. Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015 [TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency. Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021 [TBL] [Abstract][Full Text] [Related]
17. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination. Loebermann M; Voss U; Meyer S; Bosse D; Fritzsche C; Klammt S; Frimmel S; Riebold D; Reisinger EC PLoS One; 2013; 8(8):e70866. PubMed ID: 23976960 [TBL] [Abstract][Full Text] [Related]
18. Vaccination against influenza in patients with systemic sclerosis. Litinsky I; Balbir A; Zisman D; Mandelboim M; Mendelson E; Feld J; Braun Y; Anouk M; Kaufman I; Paran D; Caspi D; Elkayam O Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S7-11. PubMed ID: 22409886 [TBL] [Abstract][Full Text] [Related]
19. Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination. Soonawala D; Rimmelzwaan GF; Gelinck LB; Visser LG; Kroon FP PLoS One; 2011 Jan; 6(1):e16496. PubMed ID: 21304982 [TBL] [Abstract][Full Text] [Related]
20. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. van Assen S; Holvast A; Telgt DS; Benne CA; de Haan A; Westra J; Kallenberg CG; Bijl M Clin Immunol; 2010 Aug; 136(2):228-35. PubMed ID: 20421178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]